Optic nerve cells can be irreversibly damaged by common various causes. Unfortunately optic nerve and retinal ganglion cells have no regenerative capacity and undergo apoptosis in case of damage. In this study, our aim is to investigate the safety and efficacy of suprachoroidal umbilical cord-derived MSCs (UC-MSCs) implantation in patients with optic atrophy.
Methods:
This study enrolled 29 eyes of 23 patients with optic atrophy who were followed in the ophthalmology department of our hospital. BCVA, anterior segment, fundus examination, color photography, and optical coherence tomography (OCT) were carried out at each visit. Fundus fluorescein angiography and visual field examination were performed at the end of the first, third, sixth months, and 1 year follow-up.
Results:
After suprachoroidal UC-MSCs implantation there were statistically significant improvements in BCVA and VF results during 12 months follow-up (p < 0.05). When we evaluate the results of VF tests, the mean deviation (MD) value at baseline was −26.11 ± 8.36 (range −14.18 to −34.41). At the end of the first year it improved to −25.01 ± 8.73 (range −12.56 to −34.41) which was statistically significant (p < 0.05). When we evaluate the mean RNFL thickness measurements at baseline and at 12 month follow-up the results were 81.8 ± 24.9 μm and 76.6 ± 22.6 μm, respectively. There was not a significant difference between the mean values (p > 0.05).
Conclusion:
Stem cell treatment with suprachoroidal implantation of UCMSCs seems to be safe and effective in the treatment for optic nerve diseases that currently have no curative treatment options
GhaffariehALevinLA.Optic nerve disease and axon pathophysiology. Int Rev Neurobiol2012; 105: 1–17.
2.
DworakDPNicholsJ.A review of optic neuropathies. Dis Mon2014; 60(6): 276–281.
3.
SchwabMEKapfhammerJPBandtlowCE.Inhibitors of neurite growth. Ann Rev Neurosci1993; 16: 565–595.
4.
PernetVSchwabME.Lost in the jungle: new hurdles for optic nerve axon regeneration. Trends Neurosci2014; 37(7): 381–387.
5.
ZhaoTLiYTangL, et al. Protective effects of human umbilical cord blood stem cell intravitreal transplantation against optic nerve injury in rats. Graefes Arch Clin Exp Ophthalmol2011; 249: 1021–1028.
6.
Le BlancKMougiakakosD. Multipotent mesenchymal stromal cells and the innate immune system. Nat Rev Immunol2012; 12: 383–396.
7.
OnerA.Stem cell treatment in retinal diseases: recent developments. Turk J Ophthalmol2018; 48(1): 33–38.
8.
LeeMWJangIKYooKH, et al. Stem and progenitor cells in human umbilical cord blood. Int J Hematol2010; 92: 45–51.
9.
KimMJShinKSJeonJH, et al. Human chorionic-plate-derived mesenchymal stem cells and Wharton’s jelly-derived mesenchymal stem cells: a comparative analysis of their potential as placenta-derived stem cells. Cell Tissue Res2011; 346: 53–64.
10.
JungJChoiJHLeeY, et al. Human placenta-derived mesenchymal stem cells promote hepatic regeneration in CCl4-injured rat liver model via increased autophagic mechanism. Stem Cells2013; 31: 1584–1596.
11.
LimoliPGLimoliCVingoloEM.Cell surgery and growth factors in dry age-related macular degeneration: visual prognosis and morphological study. Oncotarget2016; 7(30): 46913–46923.
12.
OnerAGonenZBSevimDG, et al. Six-month results of suprachoroidal adipose tissue derived mesenchymal stem cell implantation in patients with optic atrophy: a phase 1/2 study. Int Ophthalmol2019; 39(12): 2913–2922.
13.
OnerAGonenZBSevimDG, et al. Suprachoroidal adipose tissue derived mesenchymal stem cell implantation in patients with dry type age-related maculardegeneration and Stargardt’s macular dystrophy: 6 month follow-up results of a phase 2 study. Cell Reprogram2018; 20(6): 329–336.
14.
MeadBBerryMLoganA, et al. Stem cell treatment of degenerative eye disease. Stem Cell Res2015; 14(3): 243–257.
15.
OnerASevimDG.Complications of stem cell based therapies in retinal diseases. Stem Cell Res Open Lib2017; 1(1): 1–7.
16.
NgTKFortinoVRPelaezD, et al. Progress of mesenchymal stem cell therapy for neural and retinal diseases. World J Stem Cells2014; 6: 111–119.
17.
ChenQLongYYuanX, et al. Protective effects of bone marrow stromal cell transplantation in injured rodent brain: synthesis of neurotrophic factors. J Neurosci Res2005; 80: 611–619.
18.
JohnsonTVBullNDHuntDP, et al. Neuroprotective effects of intravitreal mesenchymal stem cell transplantation in experimental glaucoma. Invest Ophthalmol Vis Sci2010; 51: 2051–2059.
19.
ZhangYWangW.Effects of bone marrow mesenchymal stem cell transplantation on light-damaged retina. Invest Ophthalmol Vis Sci2010; 51: 3742–3748.
20.
NautaAJFibbeWE.Immunomodulatory properties of mesenchymal stromal cells. Blood2007; 110: 3499–3506.
21.
KyurkchievDBochevIIvanova-TodorovaE, et al. Secretion of immunoregulatory cytokines by mesenchymal stem cells. World J Stem Cells2014; 6(5): 552–570.
22.
KassisIVaknin-DembinskyAKarussisD.Bone marrow mesenchymal stem cells: agents of immunomodulation and neuroprotection. Curr Stem Cell Res Ther2011; 6(1): 63–68.
23.
WangLJLiuLPGuXL, et al. Implantation of adipose-derived stem cells cures the optic nerve injury on rats through inhibiting the expression of inflammation factors in the TLR4 signaling pathway. Eur Rev Med Pharmacol Sci2011; 22: 1196–1202.
24.
YuSTanabeTDezawaM, et al. Effects of bone marrow stromal cell injection in an experimental glaucoma model. Biochem Biophys Res Commun2006; 344: 1071–1079.
25.
EmreEYükselNDuruksuG, et al. Neuroprotective effects of intravitreally transplanted adipose tissue and bone marrow– derived mesenchymal stem cells in an experimental ocular hypertension model. Cytotherapy2015; 17(5): 543–559.
26.
MeadBLoganABerryM, et al. Intravitreally transplanted dental pulp stem cells promote neuroprotection and axon regeneration of retinal ganglion cells after optic nerve injury. Invest Ophthalmol Vis Sci2013; 54: 7544–7556.
27.
JiangBZhangPZhouD, et al. Intravitreal transplantation of human umbilical cord blood stem cells protects rats from traumatic optic neuropathy. PLoS ONE2013; 8(8): e69938.
28.
MeadBBerryMLoganA, et al. Stem cell treatment of degenerative eye disease. Stem Cell Res2015; 14: 243–257.
29.
Levkovitch-VerbinHSadanOVanderS, et al. Intravitreal injections of neurotrophic factors secreting mesenchymal stem cells are neuroprotective in rat eyes following optic nerve transection. Invest Ophthalmol Vis Sci2010; 51: 6394–6400.
30.
HuZLLiNWeiX, et al. Neuroprotective effects of BDNF and GDNF in intravitreally transplanted mesenchymal stem cells after optic nerve crush in mice. Int J Ophthalmol2017; 10: 35–42.
31.
WilkinsAKempKGintyM, et al. Human bone marrow-derived mesenchymal stem cells secrete brain-derived neurotrophic factor which promotes neuronal survival in vitro. Stem Cell Res2009; 3: 63–70.
32.
Mesentier-LouroLAZaverucha-do-ValleCda Silva-JuniorAJ, et al. Distribution of mesenchymal stem cells and effects on neuronal survival and axon regeneration after optic nerve crush and cell therapy. PLoS ONE2014; 9(10): e110722.
33.
Haddad-MashadrizehABahramiARMatinMM, et al. Human adipose-derived mesenchymal stem cells can surviveand integrate into the adult rat eye following xenotransplantation. Xenotransplantation2013; 20(3): 165–176.
34.
MeadBLoganABerryM, et al. Paracrine-mediated neuroprotection and neuritogenesis of axotomised retinal ganglion cells by human dental pulp stem cells: comparison with human bone marrow and adiposederived mesenchymal stem cells. PLoS One2014; 9: e109305.
35.
SakaiKYamamotoAMatsubaraK, et al. Human dental pulp-derived stem cells promote locomotor recovery after complete transection of the rat spinal cord by multiple neuro-regenerative mechanisms. J Clin Investig2012; 122: 80–90.
36.
LiTXiaMGaoY, et al. Human umbilical cord mesenchymal stem cells: an overview of their potential in cell-based therapy. Expert Opin Biol Ther2015; 15(9): 1293–1306.
37.
FrausinSViventiSVergaFL, et al. Wharton’s jelly derived mesenchymal stromal cells: biological properties, induction of neuronal phenotype and current applications in neurodegeneration research. Acta Histochem2015; 117(4–5): 329–338.
38.
WeissJNLevySBenesSC.Stem cell ophthalmology treatment study (SCOTS) for retinal and optic nerve diseases a case report of improvement in relapsing autoimmune optic neuropathy. Neural Regen Res2015; 10(9): 1507–1515.
39.
WeissJNLevySBenesSC.Stem cell ophthalmology treatment study bone marrow derived stem cells in the treatment of nonarteritic ischemic optic neuropathy (NAION). Stem Cell Investig2017; 4: 94.
40.
WeissJNLevySMalkinA.Stem cell ophthalmology treatment study (SCOTS) for retinal and optic nerve diseases a preliminary report. Neural Regen Res2015; 10(6): 982–988.
41.
FischerMDGoldmannTWallrappC, et al. Successful subretinal delivery and monitoring of MicroBeads in mice. PLoS ONE2013; 8(1): e55173.
42.
KimJYYouYSKimSH, et al. Epiretinal membrane formation after intravitreal autologous stem cell implantation in a retinitis pigmentosa patient. Retin Cases Brief Rep2017; 11: 227–231.
43.
OnerAGonenZBSinimN, et al. Subretinal adipose tissue-derived mesenchymal stem cell implantation in advanced stage retinitis pigmentosa: a phase I clinical safety study. Stem Cell Res Ther2016; 7: 178.
44.
StoutJTFrancisPJ.Surgical approaches to gene and stem cell therapy for retinal disease. Hum Gene Ther2011; 22(5): 531–535.
